First Time Loading...

Fulgent Genetics Inc
NASDAQ:FLGT

Watchlist Manager
Fulgent Genetics Inc Logo
Fulgent Genetics Inc
NASDAQ:FLGT
Watchlist
Price: 22.25 USD 0.23%
Updated: May 17, 2024

Fulgent Genetics Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fulgent Genetics Inc
Research & Development Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Fulgent Genetics Inc
NASDAQ:FLGT
Research & Development
-$41.4m
CAGR 3-Years
-53%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CVS Health Corp
NYSE:CVS
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cigna Corp
NYSE:CI
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Fulgent Genetics Inc's Research & Development?
Research & Development
-41.4m USD

Based on the financial report for Dec 31, 2023, Fulgent Genetics Inc's Research & Development amounts to -41.4m USD.

What is Fulgent Genetics Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-50%

Over the last year, the Research & Development growth was -43%. The average annual Research & Development growth rates for Fulgent Genetics Inc have been -53% over the past three years , -50% over the past five years .